Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
20 April, 2024 17:50 IST
GlobalSpace Tech acquires 70.80% stake in Miljon Medi APP LLP
Source: IRIS | 14 Jun, 2018, 11.07AM
Rating: NAN / 5 stars.
Comments  |  Post Comment

GlobalSpace Technologies, a fast growing new-age technology company today announced acquisition of 70.80% stake in Miljon Medi APPLLP for an undisclosed sum.

Miljon Medi APP LLP is a health tech startup with B2B Digital Platform (Platform) that connects Generics pharmaceutical manufacturers to the entire Pharma channel till retail chemist. Company claims to have some of the leading Generics Manufacturers already on the Platform with an existing network of around 73 distributors & 9380 Chemists as its active users. Company’s vision is to enable quality & certified generics reach the last mile so as to benefit the patients.

For GlobalSpace, it's a strategic acquisition which would further consolidate its vision of creating truly integrated digital healthcare ecosystem. Company is having thought leadership in creating digital platform for Pharma sales force & Doctors.

Krishna Singh, MD, GlobalSpace said, ''This is a synergistic acquisition for us, we have already built an evolved digital platform for Pharma distribution including ERP, Mobile & Web app, it would provide the much-needed technical scalability & viability to Miljon Medi App. Merging GlobalSpace's tech platform with Miljon's existing network would surely provide us the initial impetus to grow this platform to be India's largest Pharma channel network.''



 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer